While this condition can be caused by diabetes, tissue disease and neurological disorders, which damage the nerves and blood ...
The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
KXMA Bismarck on MSN10h
ND Legis: Ozempic and WegovyOzempic and Wegovy ...
There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
Possibly the best of the celebrity ads was Dunkin’ Donuts ‘DunKings 2’ with Ben and Casey Affleck and a really terrific bit from Succession alum Jeremy Strong, leaning heavily into his reputation as a ...
Hims and Hers has been slammed for its Super Bowl commercial that admonished Americans for being obese and shamed the healthcare industry - then promoted its own weight loss drugs. The 60-second ...
The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
An academic study of the merger hopes to give insight into how attorneys general can strengthen certificate-of-need laws and the importance of having more power over sales. Other industry news focuses ...
Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results